What is factoring into market growth for electronic drug delivery devices and why? New market research shares key insights.
- Strained Manufacturing, Complexity Stymie In Vivo Progress
- To Fight Cancer, Gene Editing Needs To Solve Its Delivery Problem
- Is Oncology Precision Medicine Coming of Age?
- Drug Delivery Trends From 2025: Top 4 For Momentum Gains In 2026
- The Blue Crayfish: Turning Nature's Efficiency Into Safe, Bioavailable Therapeutics
- Formulation And Delivery Considerations For Cell And Gene Therapies
- Emerging RNA Delivery Strategies For Solid Tumor Oncology
- What Do Patients Appreciate? Therapeutic Innovation And Accessibility
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Key Offerings To Help Support Your OSD On Its Journey To Market
Examine several important factors needed to effectively support oral solid dosage therapeutic manufacturing and overcome the complexities involved.
-
Delivering Market Success For Pharma Partners From Concept To Patient
The development of drug delivery devices that are innovative, intuitive, patient friendly, and patient safe must address certain areas of concern that are particular to both biologic and biosimilar therapies.
-
Striking A Balance Of Speed And Quality To Deliver Next-Gen Therapeutics
Successful delivery of a bispecific antibody therapeutic to patients necessitates a manufacturing strategy that can accommodate the unique size, structure, and complexity of these molecules to ensure quality.
-
How To Achieve Precise And Flexible Dosing With Multiparticulates
For orally delivered medicines, developers often must balance a drug’s “curb appeal” — its specific delivery mechanism, taste, ease of administration, and convenience — with safety and efficacy.
-
Wet Milling Vs. Dry Milling In The Pharmaceutical Industry
Read about the considerations necessary for choosing between wet milling and dry milling for a specific active pharmaceutical ingredient.
-
Enhancing Patient Adherence Through Autoinjector Access
As autoinjectors evolve to accommodate a diverse array of chronic diseases, consider the impact of partnering with experienced device manufacturers and fill/finish providers.
-
Overcoming Challenges In Cell And Gene Therapy Containment
Review the hurdles that can slow your time to market, including the challenges in packaging high-value therapies and solutions to help you mitigate risk and simplify the journey.
-
Considerations In Development & Manufacturing Of Complex Injectables For Early Phase Studies
A niche CDMO, with specialized technologies in complex injectable development, will have greater flexibility for successful manufacture of complex injectables in early phase development of therapeutic drugs.
-
Making The Right Choice For Multiparticulate Modified Release Dosage Forms
Wurster processing is a versatile pharmaceutical development and manufacturing technique for multiparticulates in modified release dosage forms. Understand if it's the right method for your modified-release project.
-
Vial Adapter Considerations For Cell And Gene Therapy Applications
Review features that need to be considered to choose a vial adapter for cell and gene therapy drug products and a case study where vial adapter transfer devices have been used to extract lentiviruses.

